Abstract
Cystic fibrosis (CF) is a lethal, monogenic disorder that affects multiple organ sys-tems of the body. The incidence has been described before in the Middle East to be 1 in 2000 to 1 in 5800 live births, and the median survival was estimated to be from 10 to 20 years of age. The present article attempts to revisit various facets of this disease and specifically high-lights the most important lacunae that exist in treating CF. In addition, it also tries to empha-size the steps in improving the median survival of patients with CF, in these countries.

This publication has 106 references indexed in Scilit: